torcetrapib

Interviews and expert commentary tagged “torcetrapib” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results
Audio Journal of Oncology

Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results

Philip Barter Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 PHILIP BA

6 November 2007
0:00
“RADIANCE-1” Study:  Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
Audio Journal of Oncology

“RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia

JOHN KASTELEIN, Academic Medical Center, Amsterdam REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans A drug which raises HDL and reduces circulating levels of LDL has nevertheless f

27 March 2007
0:00
COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
Audio Journal of Oncology

COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk

STEVEN NISSEN, Cleveland Clinic, OH REFERENCE: N Engl J Med 2007 356 Reporting from: American College of Cardiolgy New Orleans Two big studies published in the New England Journal of Medicine and pres

26 March 2007
0:00